期刊文献+

细胞因子诱导杀伤细胞分化过程中的原子力显微镜观察

Observation of cytokine-induced killer cells during the differentiation process using atomic force microscopy
原文传递
导出
摘要 目的:利用原子力显微镜(AFM)观测细胞因子诱导的杀伤细胞(CIK)分化过程。方法:流式细胞术检测CIK表型变化,MTT法检测CIK细胞毒活性,免疫磁珠法分离CIK,AFM动态观测CIK细胞表面形态变化。结果:CIK在培养d15~d18数量达到并维持于最高水平。培养d16CIK细胞中CD3+CD8+、CD3+CD56+细胞群较d10均有不同程度的增加,分别占到(65.17±0.11)%和(17.25±0.04)%。成熟的CIK对多种肿瘤细胞均显示了较强的体外杀伤能力,利用AFM观测其细胞膜表面重要指标即平均粗糙度、峰数、平均峰值高度、平均低谷高度、表面积差值均高于培养d10细胞,P<0.01。结论:成熟CIK细胞膜表面生物蛋白分子明显增加,其细胞膜形态和功能变化密切相关。 OBJECTIVE:To observe the process of differentiation of CIK (cytokine-induced killer) using the atomic force microscopy.METHODS:The phenotype of CIK was detected by flow cytometry,the cytotoxicity was tested with MTT method and the CIK cells were separated by immunomagnetic beads.Moreover,the morphologic changes on CIK membranes were observed by AFM (atomic force microscopy).RESULTS:Between the 15 th and 18th day of culture,the number of CIK reached and maintained the highest level.On the 16th day,the CD3+CD8+ and CD3+CD56+ cells of CIK increased compared with the 10th day,which accounted to (65.17±0.11)% and (17.25±0.04)%.Mature CIK showed powerful abilities to kill and wound various kinds of tumor cells in vitro and the important AFM parameters of mean roughness,peak count,average max peak height,average max depth and surface area difference were significantly higher than those of the cells on the 10th day (P0.01).CONCLUSION:The number of membrane bioprotein on mature CIK increases intensively,and the morphous of its membrane is intimately correlated with the functional changes.
出处 《中华肿瘤防治杂志》 CAS 2010年第16期1262-1265,共4页 Chinese Journal of Cancer Prevention and Treatment
关键词 细胞因子诱导的杀伤细胞 原子力显微镜 肿瘤 流式细胞术 免疫磁珠分离 cytokine-induced killer atomic force microscopy tumor flow cytometry immunomagnetic separation
  • 相关文献

参考文献10

  • 1Nagaraj S, Ziske C, Schmidt-Wolf I G. Human cytokine -induced killer cells have enhanced in vitro cytolytic activity via non viral interleukin-2 gene gransfer[J]. Genet Vaccines Ther, 2004, 2(1):12.
  • 2Alvarnas J C, Linn Y C, Hope E G, et al. Expansion of cytotoxic CD3^+ CD56^+ cells from peripheral blood progenitor cells of patients undergoing autologous hematopoietic cell transplantation. [J]. Biol Blood Marrow Transplant, 2001,7(4) :216-222.
  • 3Hongeng S, Petvises S, Worapongpaiboon S, et al. Generation of CD3^+ CD56^ cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells[J]. Int J Hematol, 2003,77(2) :175-179.
  • 4赵明,吴沛宏,曾益新,夏建川,张福君,冼励坚,张毓平,周琨,范卫君,张亮,高飞,周启明.经肝动脉栓塞化疗序贯联合射频消融和细胞因子诱导的杀伤细胞治疗肝细胞癌的随机研究[J].中华医学杂志,2006,86(26):1823-1828. 被引量:53
  • 5撒亚莲,华映坤,严新民,贾玲,纳智明,宋建新.恶性实体瘤患者自体CIK细胞的体外扩增及初步临床应用[J].实用癌症杂志,2006,21(1):11-14. 被引量:9
  • 6Binnig G, Rohrer H. Scanning tunneling microscope[J].Helv Phys Acta,1982.55(3):726-735.
  • 7Ucda A, Niwa O, Maruyama K, et al. Neuritc imaging of living PC12 cells with scanning electrochemical/near field optical/atomic force microscopy[J]. Angew Chem lnt Ed Engl, 2007, 46 (43) :8238-8241.
  • 8Schmidt Wolf I G, Lefterova P, Mehta B A, et al. Phenotypic charact-erization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells[J].Exp Hematol, 1993,21 (13) : 1673-1679.
  • 9Ortaldo J R, Masson A, Overton R. Lymphokine-actived killer cells. Analysis of progenitor and effectors[J]. J Exp Med, 1986, 164 :1193-1205.
  • 10Hoyle C, Bangs C D, Chang P, et al. Expansion of Philadelphia chromosome negative CD3^+ CD56^+ cytoloxic cells from chronic myeloid leukemia patients: in vitro and in vivo effieacy in severe combined immunodeciency disease mice[J]. Blood, 1998,92(9): 3318-3327.

二级参考文献18

  • 1郝建峰,夏禾爱,华群,张金娣.自体CIK细胞过继免疫治疗恶性肿瘤的实验研究[J].实用医技杂志,2004,11(08B):1540-1542. 被引量:5
  • 2施明,张冰,汤紫荣,雷周云,王慧芬,冯永毅,刘敬超,范振平,李捍卫,牟劲松,王福生.肝癌患者自体细胞因子诱导杀伤细胞治疗后免疫活性细胞的检测及其临床意义[J].中华医学杂志,2003,83(23):2049-2053. 被引量:37
  • 3杨薇,陈敏华.射频消融治疗肝肿瘤疗效及其影响因素[J].中华医学杂志,2005,85(5):354-357. 被引量:13
  • 4江浩,刘开彦,童春容,江滨,陆道培.化疗联合自体细胞因子诱导杀伤细胞治疗急性白血病的临床观察[J].中华内科杂志,2005,44(3):198-201. 被引量:32
  • 5Blattman JN,Greenberg PD.Cancer immunotherapy:a treatment for the masses[J ].Science,2004,305 (5681):200.
  • 6Schmidt-Wolf IG,Lefterova P,Mehta BA,et al.Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells[J].Exp Hematol,1993,21 (13):1673.
  • 7Reichert TE,Day R,Wagner EM,et al.Absent or low expression of the zeta chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma[J].Cancer Res,1998,58(23):5344.
  • 8Yamaguchi Y,Ohshita A,Kawabuchi Y,et al.Adoptive immunotherapy of cancer using activated autologous lymphocytes-current status and new strategies[J].Hum Cell,2003,16 (4):183.
  • 9Hongeng S,Petvises S,Worapongpaiboon S,etal.Generation of CD3+CD56+cytokine-induced killer cells and their in vitro cytotoxicity against pediatric cancer cells[J].Int J Hematol,2003,77:175.
  • 10van der Vliet HJ,Nishi N,Koezuka Y,et al.Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells,cultured in the presence of IL-7 and IL-15[J].J Immunol Methods,2001,247(1-2):61.

共引文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部